Pharmaceutical formulations of bruton's tyrosine kinase inhibtor

Described herein are pharmaceutical formulations of Bruton's tyrosine kinase (Btk) inhibitor 1- ((R)-3-(4-amino-3-(4-phenoxyphenyl)-lH-pyrazolo[3,4-d]pyrimidin-l-yl)piperidin-l-yl)prop-2- en-l-one. Also disclosed are methods of using the Btk inhibitor, alone or in combination with other therape...

Full description

Saved in:
Bibliographic Details
Main Authors Chong, Ching Wah, Tan, Heow, Kuehl, Robert, Atluri, Harisha
Format Patent
LanguageEnglish
Published 23.12.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Described herein are pharmaceutical formulations of Bruton's tyrosine kinase (Btk) inhibitor 1- ((R)-3-(4-amino-3-(4-phenoxyphenyl)-lH-pyrazolo[3,4-d]pyrimidin-l-yl)piperidin-l-yl)prop-2- en-l-one. Also disclosed are methods of using the Btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
Bibliography:Application Number: NZ20160734446